- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Nsaids market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Nsaids market. Detailed analysis of key players, along with key growth strategies adopted by Nsaids industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Amgen Inc
Novacap (FR)
GSK Sharp & Dohme Corp.
Kopran Ltd.
Johnson & Johnson
Sun Pharmaceutical Industries Ltd
Bayer (DE)
GlaxoSmithKline
Geri-Care Pharmaceuticals
Abbott
Perrigo Company
Reddy Pharmaceuticals Ltd
By Type:
Aspirin
Ibuprofen
Naproxen
Nabumetone
Others
By End-User:
Back Pain Treatment
Osteoarthritis Treatment
Other Disease Treatment
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Nsaids Market
-
1.3 Market Segment by Type
1.3.1 Japan Nsaids Market Size and Growth Rate of Aspirin from 2014 to 2026
1.3.2 Japan Nsaids Market Size and Growth Rate of Ibuprofen from 2014 to 2026
1.3.3 Japan Nsaids Market Size and Growth Rate of Naproxen from 2014 to 2026
1.3.4 Japan Nsaids Market Size and Growth Rate of Nabumetone from 2014 to 2026
1.3.5 Japan Nsaids Market Size and Growth Rate of Others from 2014 to 2026
-
1.4 Market Segment by Application
1.4.1 Japan Nsaids Market Size and Growth Rate of Back Pain Treatment from 2014 to 2026
1.4.2 Japan Nsaids Market Size and Growth Rate of Osteoarthritis Treatment from 2014 to 2026
1.4.3 Japan Nsaids Market Size and Growth Rate of Other Disease Treatment from 2014 to 2026
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido Nsaids Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku Nsaids Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto Nsaids Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu Nsaids Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki Nsaids Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku Nsaids Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku Nsaids Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu Nsaids Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Nsaids Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Nsaids by Major Types
3.4.1 Market Size and Growth Rate of Aspirin
3.4.2 Market Size and Growth Rate of Ibuprofen
3.4.3 Market Size and Growth Rate of Naproxen
3.4.4 Market Size and Growth Rate of Nabumetone
3.4.5 Market Size and Growth Rate of Others
4 Segmentation of Nsaids Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Nsaids by Major End-Users
4.4.1 Market Size and Growth Rate of Nsaids in Back Pain Treatment
4.4.2 Market Size and Growth Rate of Nsaids in Osteoarthritis Treatment
4.4.3 Market Size and Growth Rate of Nsaids in Other Disease Treatment
5 Market Analysis by Regions
-
5.1 Japan Nsaids Production Analysis by Regions
-
5.2 Japan Nsaids Consumption Analysis by Regions
6 Hokkaido Nsaids Landscape Analysis
-
6.1 Hokkaido Nsaids Landscape Analysis by Major Types
-
6.2 Hokkaido Nsaids Landscape Analysis by Major End-Users
7 Tohoku Nsaids Landscape Analysis
-
7.1 Tohoku Nsaids Landscape Analysis by Major Types
-
7.2 Tohoku Nsaids Landscape Analysis by Major End-Users
8 Kanto Nsaids Landscape Analysis
-
8.1 Kanto Nsaids Landscape Analysis by Major Types
-
8.2 Kanto Nsaids Landscape Analysis by Major End-Users
9 Chubu Nsaids Landscape Analysis
-
9.1 Chubu Nsaids Landscape Analysis by Major Types
-
9.2 Chubu Nsaids Landscape Analysis by Major End-Users
10 Kinki Nsaids Landscape Analysis
-
10.1 Kinki Nsaids Landscape Analysis by Major Types
-
10.2 Kinki Nsaids Landscape Analysis by Major End-Users
11 Chugoku Nsaids Landscape Analysis
-
11.1 Chugoku Nsaids Landscape Analysis by Major Types
-
11.2 Chugoku Nsaids Landscape Analysis by Major End-Users
12 Shikoku Nsaids Landscape Analysis
-
12.1 Shikoku Nsaids Landscape Analysis by Major Types
-
12.2 Shikoku Nsaids Landscape Analysis by Major End-Users
13 Kyushu Nsaids Landscape Analysis
-
13.1 Kyushu Nsaids Landscape Analysis by Major Types
-
13.2 Kyushu Nsaids Landscape Analysis by Major End-Users
14 Major Players Profiles
14.1 Amgen Inc
14.1.1 Amgen Inc Company Profile and Recent Development
14.1.2 Market Performance
14.1.3 Product and Service Introduction
14.2 Novacap (FR)
14.2.1 Novacap (FR) Company Profile and Recent Development
14.2.2 Market Performance
14.2.3 Product and Service Introduction
14.3 GSK Sharp & Dohme Corp.
14.3.1 GSK Sharp & Dohme Corp. Company Profile and Recent Development
14.3.2 Market Performance
14.3.3 Product and Service Introduction
14.4 Kopran Ltd.
14.4.1 Kopran Ltd. Company Profile and Recent Development
14.4.2 Market Performance
14.4.3 Product and Service Introduction
14.5 Johnson & Johnson
14.5.1 Johnson & Johnson Company Profile and Recent Development
14.5.2 Market Performance
14.5.3 Product and Service Introduction
14.6 Sun Pharmaceutical Industries Ltd
14.6.1 Sun Pharmaceutical Industries Ltd Company Profile and Recent Development
14.6.2 Market Performance
14.6.3 Product and Service Introduction
14.7 Bayer (DE)
14.7.1 Bayer (DE) Company Profile and Recent Development
14.7.2 Market Performance
14.7.3 Product and Service Introduction
14.8 GlaxoSmithKline
14.8.1 GlaxoSmithKline Company Profile and Recent Development
14.8.2 Market Performance
14.8.3 Product and Service Introduction
14.9 Geri-Care Pharmaceuticals
14.9.1 Geri-Care Pharmaceuticals Company Profile and Recent Development
14.9.2 Market Performance
14.9.3 Product and Service Introduction
14.10 Abbott
14.10.1 Abbott Company Profile and Recent Development
14.10.2 Market Performance
14.10.3 Product and Service Introduction
14.11 Perrigo Company
14.11.1 Perrigo Company Company Profile and Recent Development
14.11.2 Market Performance
14.11.3 Product and Service Introduction
14.12 Reddy Pharmaceuticals Ltd
14.12.1 Reddy Pharmaceuticals Ltd Company Profile and Recent Development
14.12.2 Market Performance
14.12.3 Product and Service Introduction
The List of Tables and Figures (Totals 137 Figures and 188 Tables)
Figure Japan Nsaids Market Size and Growth Rate of Aspirin from 2014 to 2026
Figure Japan Nsaids Market Size and Growth Rate of Ibuprofen from 2014 to 2026
Figure Japan Nsaids Market Size and Growth Rate of Naproxen from 2014 to 2026
Figure Japan Nsaids Market Size and Growth Rate of Nabumetone from 2014 to 2026
Figure Japan Nsaids Market Size and Growth Rate of Others from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
Figure Japan Nsaids Market Size and Growth Rate of Back Pain Treatment from 2014 to 2026
Figure Japan Nsaids Market Size and Growth Rate of Osteoarthritis Treatment from 2014 to 2026
Figure Japan Nsaids Market Size and Growth Rate of Other Disease Treatment from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido Nsaids Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku Nsaids Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto Nsaids Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu Nsaids Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki Nsaids Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku Nsaids Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku Nsaids Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu Nsaids Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Nsaids Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Nsaids
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Nsaids by Different Types from 2014 to 2026
-
Table Consumption Share of Nsaids by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of Aspirin
Figure Market Size and Growth Rate of Ibuprofen
Figure Market Size and Growth Rate of Naproxen
Figure Market Size and Growth Rate of Nabumetone
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Nsaids by Different End-Users from 2014 to 2026
-
Table Consumption Share of Nsaids by Different End-Users from 2014 to 2026
Figure Japan Nsaids Market Size and Growth Rate of Back Pain Treatment from 2014 to 2026
Figure Japan Nsaids Market Size and Growth Rate of Osteoarthritis Treatment from 2014 to 2026
Figure Japan Nsaids Market Size and Growth Rate of Other Disease Treatment from 2014 to 2026
-
Table Japan Nsaids Production by Regions
-
Table Japan Nsaids Production Share by Regions
-
Figure Japan Nsaids Production Share by Regions in 2014
-
Figure Japan Nsaids Production Share by Regions in 2018
-
Figure Japan Nsaids Production Share by Regions in 2026
-
Table Japan Nsaids Consumption by Regions
-
Table Japan Nsaids Consumption Share by Regions
-
Figure Japan Nsaids Consumption Share by Regions in 2014
-
Figure Japan Nsaids Consumption Share by Regions in 2018
-
Figure Japan Nsaids Consumption Share by Regions in 2026
-
Table Hokkaido Nsaids Consumption by Types from 2014 to 2026
-
Table Hokkaido Nsaids Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido Nsaids Consumption Share by Types in 2014
-
Figure Hokkaido Nsaids Consumption Share by Types in 2018
-
Figure Hokkaido Nsaids Consumption Share by Types in 2026
-
Table Hokkaido Nsaids Consumption by End-Users from 2014 to 2026
-
Table Hokkaido Nsaids Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido Nsaids Consumption Share by End-Users in 2014
-
Figure Hokkaido Nsaids Consumption Share by End-Users in 2018
-
Figure Hokkaido Nsaids Consumption Share by End-Users in 2026
-
Table Tohoku Nsaids Consumption by Types from 2014 to 2026
-
Table Tohoku Nsaids Consumption Share by Types from 2014 to 2026
-
Figure Tohoku Nsaids Consumption Share by Types in 2014
-
Figure Tohoku Nsaids Consumption Share by Types in 2018
-
Figure Tohoku Nsaids Consumption Share by Types in 2026
-
Table Tohoku Nsaids Consumption by End-Users from 2014 to 2026
-
Table Tohoku Nsaids Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku Nsaids Consumption Share by End-Users in 2014
-
Figure Tohoku Nsaids Consumption Share by End-Users in 2018
-
Figure Tohoku Nsaids Consumption Share by End-Users in 2026
-
Table Kanto Nsaids Consumption by Types from 2014 to 2026
-
Table Kanto Nsaids Consumption Share by Types from 2014 to 2026
-
Figure Kanto Nsaids Consumption Share by Types in 2014
-
Figure Kanto Nsaids Consumption Share by Types in 2018
-
Figure Kanto Nsaids Consumption Share by Types in 2026
-
Table Kanto Nsaids Consumption by End-Users from 2014 to 2026
-
Table Kanto Nsaids Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto Nsaids Consumption Share by End-Users in 2014
-
Figure Kanto Nsaids Consumption Share by End-Users in 2018
-
Figure Kanto Nsaids Consumption Share by End-Users in 2026
-
Table Chubu Nsaids Consumption by Types from 2014 to 2026
-
Table Chubu Nsaids Consumption Share by Types from 2014 to 2026
-
Figure Chubu Nsaids Consumption Share by Types in 2014
-
Figure Chubu Nsaids Consumption Share by Types in 2018
-
Figure Chubu Nsaids Consumption Share by Types in 2026
-
Table Chubu Nsaids Consumption by End-Users from 2014 to 2026
-
Table Chubu Nsaids Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu Nsaids Consumption Share by End-Users in 2014
-
Figure Chubu Nsaids Consumption Share by End-Users in 2018
-
Figure Chubu Nsaids Consumption Share by End-Users in 2026
-
Table Kinki Nsaids Consumption by Types from 2014 to 2026
-
Table Kinki Nsaids Consumption Share by Types from 2014 to 2026
-
Figure Kinki Nsaids Consumption Share by Types in 2014
-
Figure Kinki Nsaids Consumption Share by Types in 2018
-
Figure Kinki Nsaids Consumption Share by Types in 2026
-
Table Kinki Nsaids Consumption by End-Users from 2014 to 2026
-
Table Kinki Nsaids Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki Nsaids Consumption Share by End-Users in 2014
-
Figure Kinki Nsaids Consumption Share by End-Users in 2018
-
Figure Kinki Nsaids Consumption Share by End-Users in 2026
-
Table Chugoku Nsaids Consumption by Types from 2014 to 2026
-
Table Chugoku Nsaids Consumption Share by Types from 2014 to 2026
-
Figure Chugoku Nsaids Consumption Share by Types in 2014
-
Figure Chugoku Nsaids Consumption Share by Types in 2018
-
Figure Chugoku Nsaids Consumption Share by Types in 2026
-
Table Chugoku Nsaids Consumption by End-Users from 2014 to 2026
-
Table Chugoku Nsaids Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku Nsaids Consumption Share by End-Users in 2014
-
Figure Chugoku Nsaids Consumption Share by End-Users in 2018
-
Figure Chugoku Nsaids Consumption Share by End-Users in 2026
-
Table Shikoku Nsaids Consumption by Types from 2014 to 2026
-
Table Shikoku Nsaids Consumption Share by Types from 2014 to 2026
-
Figure Shikoku Nsaids Consumption Share by Types in 2014
-
Figure Shikoku Nsaids Consumption Share by Types in 2018
-
Figure Shikoku Nsaids Consumption Share by Types in 2026
-
Table Shikoku Nsaids Consumption by End-Users from 2014 to 2026
-
Table Shikoku Nsaids Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku Nsaids Consumption Share by End-Users in 2014
-
Figure Shikoku Nsaids Consumption Share by End-Users in 2018
-
Figure Shikoku Nsaids Consumption Share by End-Users in 2026
-
Table Kyushu Nsaids Consumption by Types from 2014 to 2026
-
Table Kyushu Nsaids Consumption Share by Types from 2014 to 2026
-
Figure Kyushu Nsaids Consumption Share by Types in 2014
-
Figure Kyushu Nsaids Consumption Share by Types in 2018
-
Figure Kyushu Nsaids Consumption Share by Types in 2026
-
Table Kyushu Nsaids Consumption by End-Users from 2014 to 2026
-
Table Kyushu Nsaids Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu Nsaids Consumption Share by End-Users in 2014
-
Figure Kyushu Nsaids Consumption Share by End-Users in 2018
-
Figure Kyushu Nsaids Consumption Share by End-Users in 2026
Table Company Profile and Development Status of Amgen Inc
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen Inc
Figure Sales and Growth Rate Analysis of Amgen Inc
Figure Revenue and Market Share Analysis of Amgen Inc
Table Product and Service Introduction of Amgen Inc
Table Company Profile and Development Status of Novacap (FR)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novacap (FR)
Figure Sales and Growth Rate Analysis of Novacap (FR)
Figure Revenue and Market Share Analysis of Novacap (FR)
Table Product and Service Introduction of Novacap (FR)
Table Company Profile and Development Status of GSK Sharp & Dohme Corp.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK Sharp & Dohme Corp.
Figure Sales and Growth Rate Analysis of GSK Sharp & Dohme Corp.
Figure Revenue and Market Share Analysis of GSK Sharp & Dohme Corp.
Table Product and Service Introduction of GSK Sharp & Dohme Corp.
Table Company Profile and Development Status of Kopran Ltd.
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kopran Ltd.
Figure Sales and Growth Rate Analysis of Kopran Ltd.
Figure Revenue and Market Share Analysis of Kopran Ltd.
Table Product and Service Introduction of Kopran Ltd.
Table Company Profile and Development Status of Johnson & Johnson
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson
Figure Sales and Growth Rate Analysis of Johnson & Johnson
Figure Revenue and Market Share Analysis of Johnson & Johnson
Table Product and Service Introduction of Johnson & Johnson
Table Company Profile and Development Status of Sun Pharmaceutical Industries Ltd
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sun Pharmaceutical Industries Ltd
Figure Sales and Growth Rate Analysis of Sun Pharmaceutical Industries Ltd
Figure Revenue and Market Share Analysis of Sun Pharmaceutical Industries Ltd
Table Product and Service Introduction of Sun Pharmaceutical Industries Ltd
Table Company Profile and Development Status of Bayer (DE)
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer (DE)
Figure Sales and Growth Rate Analysis of Bayer (DE)
Figure Revenue and Market Share Analysis of Bayer (DE)
Table Product and Service Introduction of Bayer (DE)
Table Company Profile and Development Status of GlaxoSmithKline
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline
Figure Sales and Growth Rate Analysis of GlaxoSmithKline
Figure Revenue and Market Share Analysis of GlaxoSmithKline
Table Product and Service Introduction of GlaxoSmithKline
Table Company Profile and Development Status of Geri-Care Pharmaceuticals
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Geri-Care Pharmaceuticals
Figure Sales and Growth Rate Analysis of Geri-Care Pharmaceuticals
Figure Revenue and Market Share Analysis of Geri-Care Pharmaceuticals
Table Product and Service Introduction of Geri-Care Pharmaceuticals
Table Company Profile and Development Status of Abbott
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott
Figure Sales and Growth Rate Analysis of Abbott
Figure Revenue and Market Share Analysis of Abbott
Table Product and Service Introduction of Abbott
Table Company Profile and Development Status of Perrigo Company
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Perrigo Company
Figure Sales and Growth Rate Analysis of Perrigo Company
Figure Revenue and Market Share Analysis of Perrigo Company
Table Product and Service Introduction of Perrigo Company
Table Company Profile and Development Status of Reddy Pharmaceuticals Ltd
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Reddy Pharmaceuticals Ltd
Figure Sales and Growth Rate Analysis of Reddy Pharmaceuticals Ltd
Figure Revenue and Market Share Analysis of Reddy Pharmaceuticals Ltd
Table Product and Service Introduction of Reddy Pharmaceuticals Ltd
-